Trial · NCT02122198
Results by group33
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 33
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Changes in Prefrontal Cortex Brain Activation at 6 Months | Placebo | Frontal Pole (L) | 90.64 | Standard Deviation 3.88 | beta-weight |
| Changes in Prefrontal Cortex Brain Activation at 6 Months | GnRH Agonist | Frontal Pole (L) | -62.20 | Standard Deviation 57.61 | beta-weight |
| Changes in Prefrontal Cortex Brain Activation at 6 Months | Placebo | Frontal Orbital Cortex (L) | 28.07 | Standard Deviation 37.48 | beta-weight |
| Changes in Prefrontal Cortex Brain Activation at 6 Months | GnRH Agonist | Frontal Orbital Cortex (L) | -79.04 | Standard Deviation 71.85 | beta-weight |
| Changes in Prefrontal Cortex Brain Activation at 6 Months | Placebo | Superior Frontal Gyrus (R) | 92.45 | Standard Deviation 33.66 | beta-weight |
| Changes in Prefrontal Cortex Brain Activation at 6 Months | GnRH Agonist | Superior Frontal Gyrus (R) | -53.05 | Standard Deviation 41.13 | beta-weight |
| Changes in Prefrontal Cortex Brain Activation at 9 Months | GnRH Agonist | Frontal Pole (L) | -27.15 | Standard Deviation 67.37 | beta-weight |
| Changes in Prefrontal Cortex Brain Activation at 9 Months | GnRH Agonist | Frontal Orbital Cortex (L) | -88.87 | Standard Deviation 0.34 | beta-weight |
| Changes in Prefrontal Cortex Brain Activation at 9 Months | GnRH Agonist | Superior Frontal Gyrus (R) | -77.23 | Standard Deviation 68.22 | beta-weight |
| Changes in Artery Compliance at 6 Months | Placebo | -0.048 | Standard Deviation 0.057 | mm^2/mmhgx10^-1 | |
| Changes in Artery Compliance at 6 Months | GnRH Agonist | -0.095 | Standard Deviation 0.011 | mm^2/mmhgx10^-1 | |
| Changes in Artery Compliance at 9 Months | GnRH Agonist | -0.002 | Standard Deviation 0.006 | mm^2/mmhgx10^-1 | |
| Changes in Executive Cognitive Function: Trails A, 6 Months | Placebo | 2.79 | Standard Deviation 8.54 | seconds | |
| Changes in Executive Cognitive Function: Trails A, 6 Months | GnRH Agonist | -5.82 | Standard Deviation 3.11 | seconds | |
| Changes in Executive Cognitive Function: Trails A, 9 Months | GnRH Agonist | -5.46 | Standard Deviation 7.12 | time (seconds) | |
| Changes in Executive Cognitive Function: RAVLT, 6 Months | Placebo | -1.00 | Standard Deviation 2.65 | number of items recalled | |
| Changes in Executive Cognitive Function: RAVLT, 6 Months | GnRH Agonist | -1.38 | Standard Deviation 1.85 | number of items recalled | |
| Changes in Executive Cognitive Function: RAVLT, 9 Months | GnRH Agonist | 0 | Standard Deviation 2.00 | number of items recalled | |
| Changes in Executive Cognitive Function: Trails B, 6 Months | Placebo | 14.23 | Standard Deviation 4.77 | time (seconds) | |
| Changes in Executive Cognitive Function: Trails B, 6 Months | GnRH Agonist | -4.32 | Standard Deviation 16.27 | time (seconds) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02122198/results